Advanced Medical Solutions Group plc (AMS.L)
- Previous Close
199.00 - Open
198.60 - Bid 206.50 x --
- Ask 208.00 x --
- Day's Range
195.60 - 214.00 - 52 Week Range
168.40 - 275.83 - Volume
1,909,934 - Avg. Volume
1,077,780 - Market Cap (intraday)
439.487M - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
68.17 - EPS (TTM)
0.03 - Earnings Date Mar 19, 2025
- Forward Dividend & Yield 0.03 (1.27%)
- Ex-Dividend Date May 29, 2025
- 1y Target Est
268.88
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
www.admedsol.com1,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AMS.L
View MorePerformance Overview: AMS.L
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMS.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMS.L
View MoreValuation Measures
Market Cap
439.49M
Enterprise Value
509.01M
Trailing P/E
62.92
Forward P/E
17.92
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.51
Price/Book (mrq)
1.83
Enterprise Value/Revenue
2.87
Enterprise Value/EBITDA
17.15
Financial Highlights
Profitability and Income Statement
Profit Margin
4.00%
Return on Assets (ttm)
4.08%
Return on Equity (ttm)
2.94%
Revenue (ttm)
177.52M
Net Income Avi to Common (ttm)
7.09M
Diluted EPS (ttm)
0.03
Balance Sheet and Cash Flow
Total Cash (mrq)
17.04M
Total Debt/Equity (mrq)
35.84%
Levered Free Cash Flow (ttm)
-9.41M